These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3338500)

  • 1. Measles in developing countries. Part I. Epidemiological parameters and patterns.
    McLean AR; Anderson RM
    Epidemiol Infect; 1988 Feb; 100(1):111-33. PubMed ID: 3338500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Optimal age for vaccination against measles].
    José MV; Kumate J
    Salud Publica Mex; 1989; 31(5):645-57. PubMed ID: 2692194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes.
    Anderson RM; May RM
    J Hyg (Lond); 1985 Jun; 94(3):365-436. PubMed ID: 4008922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles in developing countries. Part II. The predicted impact of mass vaccination.
    McLean AR; Anderson RM
    Epidemiol Infect; 1988 Jun; 100(3):419-42. PubMed ID: 3378585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decay of maternally derived measles antibody in central Turkey.
    Metintaş S; Akgün Y; Arslantaş D; Kalyoncu C; Uçar B
    Public Health; 2002 Jan; 116(1):50-4. PubMed ID: 11896637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rural Kenya: measles during pregnancy and early infancy.
    Arya SC; Agarwal N
    J Infect Dis; 2006 Jan; 193(1):165-6; author reply 166-7. PubMed ID: 16323147
    [No Abstract]   [Full Text] [Related]  

  • 8. Population immunity to measles in the United States, 1999.
    Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
    J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles vaccine: immunity, reinfection and revaccination.
    Linnemann CC
    Am J Epidemiol; 1973 Jun; 97(6):365-71. PubMed ID: 4713932
    [No Abstract]   [Full Text] [Related]  

  • 10. Measles active and passive immunity in a worldwide perspective.
    Black FL
    Prog Med Virol; 1989; 36():1-33. PubMed ID: 2685909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of serological examinations in the epidemiological study of measles].
    Topciu V; Moldovan E; Plavoşin L; Csaky N
    Stud Cercet Virusol; 1973; 24(6):453-9. PubMed ID: 4129498
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel strategies for an effective measles vaccination programme under field conditions.
    Arya SC
    Vaccine; 1993; 11(3):391. PubMed ID: 8447166
    [No Abstract]   [Full Text] [Related]  

  • 13. Appropriate age for measles vaccination in the United States.
    Orenstein WA; Markowitz L; Preblud SR; Hinman AR; Tomasi A; Bart KJ
    Dev Biol Stand; 1986; 65():13-21. PubMed ID: 3549395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of human immunodeficiency virus-1 infection and stunting on measles immunoglobulin-G levels in children vaccinated against measles in Uganda.
    Waibale P; Bowlin SJ; Mortimer EA; Whalen C
    Int J Epidemiol; 1999 Apr; 28(2):341-6. PubMed ID: 10342701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles antibody levels in 3 to 9 months old infants.
    Dongre ST; Biranjan JR; Jalgaonkar SV; Polakhare JK
    Indian Pediatr; 1989 Aug; 26(8):775-9. PubMed ID: 2620978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serological evidence of persistent elimination of measles in Czechoslovakia].
    Strauss J; Svandová E; Smelhausová M; Mrázová M
    Cas Lek Cesk; 1989 Mar; 128(13):399-403. PubMed ID: 2790867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunologic evaluation of measles vaccine in preschool and school children].
    Soto C; Cordero J; Vergara MI
    Rev Chil Pediatr; 1981; 52(6):491-5. PubMed ID: 7347862
    [No Abstract]   [Full Text] [Related]  

  • 18. Seroepidemiology of measles in Bombay.
    Mehta NA; Nanavati AN; Jhala HI; Sant MV
    Indian J Med Res; 1972 May; 60(5):661-9. PubMed ID: 4663234
    [No Abstract]   [Full Text] [Related]  

  • 19. Loss of maternally acquired measles antibodies in well-nourished infants and response to measles vaccination, Peru.
    Vaisberg A; Alvarez JO; Hernandez H; Guillen D; Chu P; Colarossi A
    Am J Public Health; 1990 Jun; 80(6):736-8. PubMed ID: 2343967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles immunity in the first year after birth and the optimum age for vaccination in Kenyan children. Collaborative study by the Ministry of Health of Kenya and the World Health Organization.
    Bull World Health Organ; 1977; 55(1):21-31. PubMed ID: 302153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.